Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;11(4):423-34.
doi: 10.1093/europace/eun369. Epub 2009 Jan 18.

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

Affiliations

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

Michael Nabauer et al. Europace. 2009 Apr.

Abstract

Aims: The aim of this study was to describe the characteristics of patients with atrial fibrillation (AF) enrolled in the Central Registry of the German Competence NETwork on Atrial Fibrillation (AFNET) and to assess current medical practice in patients treated at various levels of medical care in Germany.

Methods and results: From February 2004 to March 2006, 9582 ambulatory and hospitalized patients with ECG-documented AF were enrolled by 194 participating study centres from all levels of medical care in Germany. Clinical type of AF was reported as paroxysmal in 2893, persistent in 1873, and permanent in 3134 patients or classified as a first episode in 1035 patients. Predisposing conditions were common and present in 87.6% of the patients. Most patients were symptomatic with AF (75.1%). Rhythm control in persistent AF was provided to 53.4% of the symptomatic patients and to 47.8% of the patients without symptoms. Anticoagulation for stroke prevention was given to 71.4% of the patients considered eligible by applicable guidelines and to 48.4% of patients with low risk where guidelines do not recommend anticoagulation.

Conclusion: This registry provides insight into current medical care of patients with AF in Germany. The use of oral anticoagulation in eligible patients was among the highest reported, whereas decisions on rate and rhythm control often do not follow current recommendations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age distribution for men and women enrolled in the central patient registry of the German AFNET. The male/female ratio was 1.6; 22.2% of men and 40.1% of women were 75 years or older.
Figure 2
Figure 2
Shift of atrial fibrillation type from paroxysmal to permanent in relation to concomitant conditions known to promote atrial fibrillation. Factors counted were age ≥75 years, hypertension, diabetes, cardiomyopathy, heart failure, valve disease or replacement.
Figure 3
Figure 3
Anti-thrombotic treatment of patients eligible and ineligible for oral anticoagulation according to the ACC/AHA/ESC Guidelines 2001, applicable during recruitment of the patients. Stroke risk factors are given in Appendix 1. Overall, 71.4% of the eligible patients received anticoagulation (oral anticoagulation or low-molecular-weight heparin for anticoagulation purposes). In patients not eligible, anticoagulation was given in 49.4%. OAC, oral anticoagulation; LMWH, low-molecular-weight heparin; antiplatelet, aspirin, clopidogrel, or ticlopidine.

Comment in

References

    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8. - PubMed
    1. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290:1049–56. - PubMed
    1. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980–1998. Am J Epidemiol. 2002;155:819–26. - PubMed
    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5. - PubMed
    1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852–923. - PubMed

Publication types

MeSH terms